Data safety and monitoring boards

被引：64

作者：

Slutsky, AS

Lavery, JV

机构：

[1] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada

[2] St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada

[3] St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada

[4] St Michaels Hosp, Inner City Hlth Res Unit, Toronto, ON M5B 1W8, Canada

[5] Univ Toronto, Dept Med, Toronto, ON, Canada

[6] Univ Toronto, Dept Surg, Toronto, ON, Canada

[7] Univ Toronto, Dept Biomed Engn, Toronto, ON, Canada

[8] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada

[9] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 11期

关键词：

D O I：

10.1056/NEJMsb033476

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1143 / 1147

页数：5

共 21 条

[1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
Abraham, E
Reinhart, K
Opal, S
Demeyer, I
Doig, C
Rodriguez, AL
Beale, R
Svoboda, P
Laterre, PF
Simon, S
Light, B
Spapen, H
Stone, J
Seibert, A
Peckelsen, C
De Deyne, C
Postier, R
Pettilä, V
Sprung, CL
Artigas, A
Percell, SR
Shu, V
Zwingelstein, C
Tobias, J
Poole, L
Stolzenbach, JC
Creasey, AA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
[2] Investigators' responsibilities for human subjects in developing countries
Angell, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) : 967 - 969
[3] [Anonymous], 2002, Data monitoring committees in clinical trials: A practical perspective
[4] EARLY STOPPING RULES - CLINICAL PERSPECTIVES AND ETHICAL CONSIDERATIONS
BAUM, M
HOUGHTON, J
ABRAMS, K
[J]. STATISTICS IN MEDICINE, 1994, 13 (13-14) : 1459 - 1469
[5] Statistical approaches and policies for the operations of Data and Safety Monitoring Committees
Califf, RM
Ellenberg, SS
[J]. AMERICAN HEART JOURNAL, 2001, 141 (02) : 301 - 305
[6] INTERIM ANALYSIS - THE ALPHA-SPENDING FUNCTION-APPROACH
DEMETS, DL
LAN, KKG
[J]. STATISTICS IN MEDICINE, 1994, 13 (13-14) : 1341 - 1352
[7] Should data and safety monitoring boards share confidential interim data?
Dixon, DO
Lagakos, SW
[J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (01): : 1 - 6
[8] *FDA, 2001, GUID CLIN TRIAL SPON
[9] Monitoring clinical trials: issues and controversies regarding confidentiality
Fleming, TR
Ellenberg, S
DeMets, DL
[J]. STATISTICS IN MEDICINE, 2002, 21 (19) : 2843 - 2851
[10] Gordon Valery M, 1998, IRB, V20, P1, DOI 10.2307/3564020

← 1 2 3 →